169 related articles for article (PubMed ID: 12920030)
1. Caspase-independent cell death in AML: caspase inhibition in vitro with pan-caspase inhibitors or in vivo by XIAP or Survivin does not affect cell survival or prognosis.
Carter BZ; Kornblau SM; Tsao T; Wang RY; Schober WD; Milella M; Sung HG; Reed JC; Andreeff M
Blood; 2003 Dec; 102(12):4179-86. PubMed ID: 12920030
[TBL] [Abstract][Full Text] [Related]
2. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces antiapoptotic and proapoptotic signals in acute myeloid leukemia.
Faderl S; Harris D; Van Q; Kantarjian HM; Talpaz M; Estrov Z
Blood; 2003 Jul; 102(2):630-7. PubMed ID: 12663443
[TBL] [Abstract][Full Text] [Related]
3. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
[TBL] [Abstract][Full Text] [Related]
4. Rapid induction of mitochondrial events and caspase-independent apoptosis in Survivin-targeted melanoma cells.
Liu T; Brouha B; Grossman D
Oncogene; 2004 Jan; 23(1):39-48. PubMed ID: 14712209
[TBL] [Abstract][Full Text] [Related]
5. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs.
Tamm I; Wang Y; Sausville E; Scudiero DA; Vigna N; Oltersdorf T; Reed JC
Cancer Res; 1998 Dec; 58(23):5315-20. PubMed ID: 9850056
[TBL] [Abstract][Full Text] [Related]
6. XIAP expression correlates with monocytic differentiation in adult de novo AML: impact on prognosis.
Tamm I; Richter S; Scholz F; Schmelz K; Oltersdorf D; Karawajew L; Schoch C; Haferlach T; Ludwig WD; Wuchter C
Hematol J; 2004; 5(6):489-95. PubMed ID: 15570290
[TBL] [Abstract][Full Text] [Related]
7. Ciglitazone induces caspase-independent apoptosis through down-regulation of XIAP and survivin in human glioma cells.
Kang DW; Choi CH; Park JY; Kang SK; Kim YK
Neurochem Res; 2008 Mar; 33(3):551-61. PubMed ID: 17940898
[TBL] [Abstract][Full Text] [Related]
8. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
Kim S; Kang J; Qiao J; Thomas RP; Evers BM; Chung DH
J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
[TBL] [Abstract][Full Text] [Related]
9. High expression levels of x-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de novo acute myeloid leukemia.
Tamm I; Richter S; Oltersdorf D; Creutzig U; Harbott J; Scholz F; Karawajew L; Ludwig WD; Wuchter C
Clin Cancer Res; 2004 Jun; 10(11):3737-44. PubMed ID: 15173080
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients.
Chen P; Li J; Ge LP; Dai CH; Li XQ
Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890
[TBL] [Abstract][Full Text] [Related]
11. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
12. Expression and prognostic significance of survivin in de novo acute myeloid leukaemia.
Adida C; Recher C; Raffoux E; Daniel MT; Taksin AL; Rousselot P; Sigaux F; Degos L; Altieri DC; Dombret H
Br J Haematol; 2000 Oct; 111(1):196-203. PubMed ID: 11091201
[TBL] [Abstract][Full Text] [Related]
13. Study of survivin and X-linked inhibitor of apoptosis protein (XIAP) genes in acute myeloid leukemia (AML).
Ibrahim AM; Mansour IM; Wilson MM; Mokhtar DA; Helal AM; Al Wakeel HM
Lab Hematol; 2012 Mar; 18(1):1-10. PubMed ID: 22459568
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of survivin by Granzyme M triggers degradation of the survivin-X-linked inhibitor of apoptosis protein (XIAP) complex to free caspase activity leading to cytolysis of target tumor cells.
Hu D; Liu S; Shi L; Li C; Wu L; Fan Z
J Biol Chem; 2010 Jun; 285(24):18326-35. PubMed ID: 20406824
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.
Blanc-Brude OP; Mesri M; Wall NR; Plescia J; Dohi T; Altieri DC
Clin Cancer Res; 2003 Jul; 9(7):2683-92. PubMed ID: 12855648
[TBL] [Abstract][Full Text] [Related]
16. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia.
Carter BZ; Milella M; Tsao T; McQueen T; Schober WD; Hu W; Dean NM; Steelman L; McCubrey JA; Andreeff M
Leukemia; 2003 Nov; 17(11):2081-9. PubMed ID: 12970762
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria.
Zhang XD; Zhang XY; Gray CP; Nguyen T; Hersey P
Cancer Res; 2001 Oct; 61(19):7339-48. PubMed ID: 11585775
[TBL] [Abstract][Full Text] [Related]
18. Targeting Survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells.
Carter BZ; Wang RY; Schober WD; Milella M; Chism D; Andreeff M
Cell Cycle; 2003; 2(5):488-93. PubMed ID: 12963850
[TBL] [Abstract][Full Text] [Related]
19. Survivin inhibition induces human neural tumor cell death through caspase-independent and -dependent pathways.
Shankar SL; Mani S; O'Guin KN; Kandimalla ER; Agrawal S; Shafit-Zagardo B
J Neurochem; 2001 Oct; 79(2):426-36. PubMed ID: 11677271
[TBL] [Abstract][Full Text] [Related]
20. Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP.
Liu JJ; Guo YW; Fang ZG; Si XN; Wu XY; Liu PQ; Lin DJ; Xiao RZ; Xu Y; Wang CZ; Li XD; He Y; Huang RW
Int J Mol Med; 2009 Nov; 24(5):623-32. PubMed ID: 19787196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
